Organigram Inc. joined Bedrocan (BED) on  Monday as another licensed Canadian medical cannabis cultivation company to become a publicly traded licensed producer under Canada’s Marijuana for Medical Purposes Regulations (MMPR), offering investors an alternative to Tweed (TWD) in the budding market.

 After completing its reverse merger and a mandatory trading halt, investors can now purchase the stock under the ticker symbol “OGI”.

Canada’s medical marijuana market is expected to grow from $179 million to $1.34 billion over the next ten years, according to Health Canada, with the patient population jumping from 41,384 to 308,755. With only 13 licensed producers approved to date, investors in OrganiGram have a unique opportunity to capitalize on the growing demand at a very early stage for the industry.

Read Full Story On: cannabisfn